# Maximus, Inc.: Form 10-Q for the period ended Dec 31, 2022

- Company: [Maximus, Inc.](/companies/mms.md) (CIK 1032220)
- Form: 10-Q
- Filed: 2023-02-09
- Accepted by EDGAR: Feb 9, 2023, 18:34 ET
- Period: 2022-12-31
- Accession: 0001032220-23-000004
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1032220/000103222023000004/mms-20221231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1032220/000103222023000004/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-10-01 to 2022-12-31 | $1.25bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2022-10-01 to 2022-12-31 | $1.00bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2022-10-01 to 2022-12-31 | $244.7m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2022-10-01 to 2022-12-31 | $146.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2022-10-01 to 2022-12-31 | $74.8m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2022-10-01 to 2022-12-31 | $13.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-10-01 to 2022-12-31 | $40.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-10-01 to 2022-12-31 | $0.65 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-10-01 to 2022-12-31 | $0.65 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-10-01 to 2022-12-31 | 61,196,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2022-10-01 to 2022-12-31 | −$134.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2022-10-01 to 2022-12-31 | $15.7m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 3 months, 2022-10-01 to 2022-12-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2022-12-31 | $63.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-12-31 | $1.26bn | us-gaap:AssetsCurrent |
| Total assets | at 2022-12-31 | $4.23bn | us-gaap:Assets |
| Current liabilities | at 2022-12-31 | $746.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-12-31 | $2.65bn | us-gaap:Liabilities |
| Long-term debt | at 2022-12-31 | $1.49bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2022-12-31 | $77.5m | us-gaap:LongTermDebtCurrent |

## Management's discussion and analysis

As filed, 29,973 characters.

*The following discussion is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with "Risk Factors," "Forward-Looking Statements," and our financial statements and related notes included in our Annual Report on Form 10-K for fiscal year 2022 filed with the Securities and Exchange Commission on November 22, 2022 (the "2022 Form 10-K") and elsewhere in this Quarterly Report on Form 10-Q, as applicable.*

### Business Overview

We are a global company with approximately 39,500 employees and 12,550 contingent workers dedicated to helping governments on four continents to administer their citizen-facing programs. Under our mission of *Moving People Forward*, we offer industry-leading expertise, including citizen engagement, eligibility and program integrity, independent clinical assessments and case management, and technology modernization services to enable citizens around the globe to successfully engage with their governments at all levels. We are instrumental in helping people who need governmental support get it.

Over the past five years, we have executed a three-pronged growth strategy: we have evolved through our digital transformation to meet the modernization needs of our clients; we have expanded our clinical assessment capabilities to meet growing demand for independent and conflict-free clinical services; and we have expanded our markets, both organically and through acquisitions.

In fiscal year 2022, we refreshed our strategy and updated the three pillars on which we will focus growth efforts for the next three to five years:

- Customer Services, Digitally Enabled. We apply proven technologies, data, and best practices to make government programs more customer-focused, effective, and deserving of the public's trust. We make it easier for people to connect to government services based on their individual preferences and abilities. We are elevating the customer experience to achieve higher levels of satisfaction, performance, and outcomes through intelligent automation and cognitive computing.
- Future of Health. We are expanding our clinical-related services and are experienced at delivering clinical BPS services at scale. We have established an extensive set of services that frequently requires a network of healthcare professionals who can complete clinical assessments, provide occupational health and independent medical review services, and adjudicate complicated benefits appeals. With the formation of Maximus Public Health ("MPH"), we are able to serve as a resource to governments as they respond to public health threats and address lessons learned from the global pandemic.
- Advanced Technologies for Modernization. We are furthering our credibility as a technology leader, enabling the transformation of government programs to be resilient, dynamic, integrated, and equitable. Leveraging our deep relationships and program knowledge, we are delivering technology-driven business transformation of government missions with a strategic near-term focus on hybrid cloud solutions, information intelligence, and hyper-automation.

### Financial Overview

A number of factors have affected our results for the first quarter of fiscal year 2023, the most significant of which we have listed below. More detail on these changes is presented below within our "Results of Operations" section.

- Our results have been tempered by the strength of the United States Dollar compared to the other currencies in which we do business.
- Although we have reported growth in all three segments, our profit margins within the United States in our current year are lower than in prior years. The end of short-term pandemic-related work, which had higher margins, is the principal driver.
- Our work in both periods has been affected by the ongoing public health emergency. Our results in future periods are expected to receive the benefit of increases in transaction-based work which was reduced or suspended as a result of the pandemic.
- The cost of financing our debt has increased year-over-year as interest rates have increased.

### Results of Operations

The following table sets forth items from our consolidated statements of operations for the three months ended December 31, 2022 and December 31, 2021.

*Table MD&A 1: Consolidated Results of Operations*

*(dollars in thousands, except per share data)*

|  | For the Three Months Ended December 31, 2022 | December 31, 2021 |
| --- | ---: | ---: |
| Revenue | $1,249,246 | $1,150,876 |
| Cost of revenue | 1,004,499 | 922,721 |
| Gross profit | 244,747 | 228,155 |
| **Gross profit percentage** | **19.6 %** | **19.8 %** |
| Selling, general, and administrative expenses | 146,452 | 124,221 |
| **Selling, general, and administrative expenses as a percentage of revenue** | **11.7 %** | **10.8 %** |
| Amortization of intangible assets | 23,518 | 22,405 |
| Operating income | 74,777 | 81,529 |
| **Operating margin** | **6.0 %** | **7.1 %** |
| Interest expense | 21,606 | 9,638 |
| Other income/(expense), net | 266 | (311) |
| Income before income taxes | 53,437 | 71,580 |
| Provision for income taxes | 13,442 | 18,250 |
| **Effective tax rate** | **25.2 %** | **25.5 %** |
| Net income | $39,995 | $53,330 |
| Earnings per share: |  |  |
| Basic | $0.65 | $0.86 |
| Diluted | $0.65 | $0.85 |

Our business segments have different factors driving revenue fluctuations and profitability. The sections that follow cover these segments in greater detail. Our revenue reflects fees earned for services provided. Cost of revenue consists of direct costs related to labor and related overhead, subcontractor labor, outside vendors, rent, and other direct costs. The largest component of cost of revenue, approximately two-thirds, is labor, including subcontracted labor.

*Table MD&A 2: Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended December 31, 2022*

*(dollars in thousands)*

|  | Revenue Dollars | % Change | Cost of Revenue Dollars | % Change | Gross Profit Dollars | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Three Months Ended December 31, 2021 | $1,150,876 |  | $922,721 |  | $228,155 |  |
| Organic effect | 118,643 | 10.3% | 98,924 | 10.7% | 19,719 | 8.6% |
| Acquired growth | 2,113 | 0.2% | 1,256 | 0.1% | 857 | 0.4% |
| Currency effect compared to the prior period | (22,386) | (1.9)% | (18,402) | (2.0)% | (3,984) | (1.7)% |
| Three Months Ended December 31, 2022 | $1,249,246 | 8.5% | $1,004,499 | 8.9% | $244,747 | 7.3% |

#### Selling, general, and administrative expenses ("SG&A")

Selling, general, and administrative expenses ("SG&A") consist of indirect costs related to general management, marketing, and administration. It is primarily composed of labor costs. These costs may be incurred at a segment level, for dedicated resources that are not client-facing, or at a corporate level. Corporate costs are allocated to segments on a consistent and rational basis. Fluctuations in our SG&A are primarily driven by changes in our administrative cost base, which is not directly driven by changes in our revenue. As part of our work for the U.S. federal government and many states, we allocate these costs using a methodology driven by the U.S. Federal Cost Accounting Standards.

Our SG&A expense has increased year-over-year primarily driven by growth in our business, including additional spending in anticipation of future work, and approximately $6.5 million related to severance programs anticipated to reduce costs in future periods.

#### Interest Expense

Our interest expense increased from $9.6 million in the first quarter of fiscal year 2022 to $21.6 million in the first quarter of fiscal year 2023, principally driven by increases in our interest rate. Our effective interest rate at December 31, 2022 was 6.0%, compared to 2.3% at December 31, 2021. We have mitigated our risk by fixing interest rates on $500 million of our debt and our near term capital allocation plan continues to prioritize reducing our debt using our free cash flow.

#### Provision for Income Taxes

Our effective income tax rate for the three months ended December 31, 2022 and 2021, was 25.2 % and 25.5 %, respectively. For fiscal year 2023, we expect the effective tax rate to be between 24.5% and 25.5%.

### U.S. Federal Services Segment

Our U.S. Federal Services Segment delivers end-to-end solutions that help various U.S. federal government agencies better deliver on their mission, including program operations and management, clinical services, and technology solutions. This also includes appeals and assessments services, system and application development, IT modernization, and maintenance services. The segment also contains certain state-based assessments and appeals work that is part of the segment's heritage which continues to be managed within this segment. Benefiting from the 2021 acquisition of the Attain Federal business, now managed as Technology Consulting Services, the segment executes on its digital strategy to deliver technology solutions that advance agency missions, including the challenge to modernize, provide better customer experience, and drive process efficiencies. The segment continues to expand its clinical solutions with the acquisition of VES Group, Inc., which manages the clinical evaluation process for U.S. veterans and service members on behalf of the U.S. Department of Veterans Affairs.

*Table MD&A 3: U.S. Federal Services Segment - Financial Results*

*(dollars in thousands)*

|  | For the Three Months Ended December 31, 2022 | December 31, 2021 |
| --- | ---: | ---: |
| Revenue | $618,167 | $581,871 |
| Cost of revenue | 495,473 | 455,295 |
| Gross profit | 122,694 | 126,576 |
| Selling, general, and administrative expenses | 71,649 | 64,925 |
| Operating income | 51,045 | 61,651 |
| Gross profit percentage | 19.8% | 21.8% |
| Operating margin percentage | 8.3% | 10.6% |

Our revenue and cost of revenue for the three months ended December 31, 2022, increased 6.2% and 8.8%, respectively. All growth in fiscal year 2023 was organic and net of anticipated declines in short-term work related to the pandemic.

Our U.S. Federal Services business grew from higher volumes in clinical services due, in part, to new wins and from the expansion of a large, cost-plus contract. As is typically the case, such contracts record lower margins than transaction-based work. Fiscal year 2022 also received some benefit from short-term, higher-margin work related to the pandemic.

We anticipate that our U.S. Federal Services business will continue to grow in fiscal year 2023, driven primarily by additional volumes anticipated in the VES business. We anticipate operating margins will range between 10% and 11%.

### U.S. Services Segment

Our U.S. Services Segment provides a variety of business process services ("BPS"), such as program administration, assessments, and related consulting work for U.S. state and local government programs. These services support a variety of programs, including the Affordable Care Act ("ACA"), Medicaid, the Children's Health Insurance Program ("CHIP"), Temporary Assistance to Needy Families ("TANF"), and child support programs. As part of the government's COVID-19 response efforts, the segment supported contact tracing, disease investigation, and vaccine distribution support services during the peak of the pandemic. The segment also successfully expanded into the unemployment insurance market where longer term opportunities have materialized. As part of the broader strategy to evolve clinically and address societal macro trends such as aging populations and rising costs, the segment continues to expand its offerings in public health with new work in in-person assessments.

*Table MD&A 4: U.S. Services Segment - Financial Results*

*(dollars in thousands)*

|  | For the Three Months Ended December 31, 2022 | December 31, 2021 |
| --- | ---: | ---: |
| Revenue | $439,478 | $386,417 |
| Cost of revenue | 355,880 | 296,718 |
| Gross profit | 83,598 | 89,699 |
| Selling, general, and administrative expenses | 45,842 | 35,102 |
| Operating income | 37,756 | 54,597 |
| Gross profit percentage | 19.0% | 23.2% |
| Operating margin percentage | 8.6% | 14.1% |

Our revenue and cost of revenue for the three months ended December 31, 2022, increased 13.7% and 19.9%, respectively, compared to three months ended December 31, 2021. All movement was organic and net of anticipated declines in short-term work related to the pandemic.

New business has increased revenue but margins remain tempered as the short-term, pandemic-related work from prior years has declined.

This segment is expected to see the greater benefit from the resumption of Medicaid eligibility redeterminations, following passage of the Consolidated Appropriations Act, 2023 (the omnibus spending bill) which decouples redeterminations from the end of the Public Health Emergency (PHE). Subsequent to the passage of the omnibus spending bill, President Biden on January 30, 2023 announced plans to end the existing PHE and national emergency declarations on May 11, 2023. While this will impact areas of healthcare delivery such as COVID testing, treatment and telemedicine, the decoupling of Medicaid redeterminations under the omnibus spending bill effectively superseded this decision by the administration. The nature and timing of the benefit will be dependent upon how the states coordinate the return of these services, but we anticipate that services will commence during our third fiscal quarter, with a greater contribution in the final quarter of the year. We anticipate a full year operating profit margin will be between 9% and 11%.

### Outside the U.S. Segment

Our Outside the U.S. Segment provides BPS for international governments and commercial clients, transforming the lives of people around the world. Helping people find employment, access vital support, and remain healthy, these services include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker related services. We support programs and deliver services in the U.K., including the Health Assessment Advisory Service ("HAAS") and Restart; Australia, including Workforce Australia (formerly jobactive) and the Disability Employment Service; Canada, including the Employment Program of British Columbia; in addition to Italy, Saudi Arabia, Singapore, South Korea, Sweden, and UAE, where we predominantly provide employment support and job seeker services.

*Table MD&A 5: Outside the U.S. Segment - Financial Results*

*(dollars in thousands)*

|  | For the Three Months Ended December 31, 2022 | December 31, 2021 |
| --- | ---: | ---: |
| Revenue | $191,601 | $182,588 |
| Cost of revenue | 153,146 | 170,708 |
| Gross profit | 38,455 | 11,880 |
| Selling, general, and administrative expenses | 28,389 | 21,340 |
| Operating (loss)/income | 10,066 | (9,460) |
| Gross profit percentage | 20.1% | 6.5% |
| Operating margin percentage | 5.3% | (5.2)% |

*Table MD&A 6: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue and Gross Profit*

*(dollars in thousands)*

|  | Revenue Amount | % Change | Cost of Revenue Amount | % Change | Gross Profit Amount | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Three Months Ended December 31, 2021 | $182,588 |  | $170,708 |  | $11,880 |  |
| Organic effect | 29,286 | 16.0% | (416) | (0.2)% | 29,702 | 250.0% |
| Acquired growth | 2,113 | 1.2% | 1,256 | 0.7% | 857 | 7.2% |
| Currency effect compared to the prior period | (22,386) | (12.3)% | (18,402) | (10.8)% | (3,984) | (33.5)% |
| Three Months Ended December 31, 2022 | $191,601 | 4.9% | $153,146 | (10.3)% | $38,455 | 223.7% |

This segment experienced significant organic revenue growth with stable costs. This benefit was partially offset by significant declines in the value of international currencies against the United States Dollar.

Our organic revenue growth is principally driven by the United Kingdom Restart contract, which is now at full capacity; our margins in fiscal year 2022 were tempered as the Restart contract was still ramping up. Within our Australian business, we have taken steps to reduce costs to reflect the decline in our work.

Much of our revenue growth stems from our employment services contracts, where we are paid based upon our ability to place individuals in long-term sustained employment. As a result, changes in our estimates of our ability to place people in work and the time that this will take can have significant effects on our revenue. Our estimates are based upon historical performance, where appropriate and available, and are constantly updated. This segment also includes a large software implementation project where revenue is based upon estimates of our anticipated overall performance. Changes in this estimate are recorded upon as a cumulative adjustment to revenue. There were no significant adjustments in this fiscal quarter.

We anticipate our Outside the United States Segment will experience greater stability in fiscal year 2023, with less disruption from residual pandemic factors and underpinned by our core programs. We anticipate operating margins will range between 3% and 7% for the full fiscal year.

### Liquidity and Capital Resources

Our primary sources of liquidity are cash on hand, cash from operations, and availability under our revolving credit facilities. As of December 31, 2022, we had $63.1 million in cash and cash equivalents. We believe that our current cash position, access to our revolving debt, and cash flow generated from operations should be not only sufficient for our operating requirements but also to enable us to fund required long-term debt repayments, dividends and any share purchases we might choose to make. See "Note 6. Debt and Derivatives" to the Consolidated Financial Statements for a more detailed discussion of our debt financing arrangements.

During the first quarter of fiscal year 2023, we entered into a number of debt-related transactions.

- We entered into an additional interest rate swap, to bring the total balance of our credit facility subject to fixed rates to $500 million. This allows us greater opportunity to predict and manage our interest payments.
- We amended both our debt and the corresponding interest rate swaps to use interest rates based upon the Secured Overnight Financing Rate (SOFR), replacing the previous LIBOR basis. This transaction anticipates the phasing out of LIBOR rates in 2023.
- As part of the transition to SOFR, we took the opportunity to redeem some of our Term Loan B debt, which we repaid using our revolving credit facility.

*Table MD&A 7: Net Change in Cash and Cash Equivalents and Restricted Cash*

*(in thousands)*

| Operating activities: | For the Three Months Ended December 31, 2022 | December 31, 2021 |
| --- | ---: | ---: |
| Net cash used in operating activities | $(134,659) | $(2,919) |
| Net cash used in investing activities | (15,697) | (6,327) |
| Net cash provided by financing activities | 170,967 | 54,916 |
| Effect of foreign exchange rates on cash and cash equivalents and restricted cash | 2,421 | 372 |
| Net change in cash and cash equivalents and restricted cash | $23,032 | $46,042 |

#### Net Cash Used In Operating Activities

Net cash used in operating activities was $134.7 million in fiscal year 2023. Our first fiscal quarter is typically light for cash flow as collections often slow in December, bonus payments are made and, in recent years, we have paid deferred payroll taxes. The biggest driver of this decline was due to strong collections experienced in the fourth quarter of last year, followed by delays in December. Our Days Sales Outstanding ("DSO") at September 30, 2022 was 62 days; the corresponding DSO at December 31, 2022 was 74 days. We anticipate improved collections through the remainder of the year; by the end of January we had already received sufficient funds to pay down approximately $75 million of revolving debt. Operating cash flows were also affected by increases in the costs of servicing our debt, owing to rising interest rates.

#### Net Cash Used In Investing Activities

Investing activities in fiscal years 2023 and 2022 reflect acquisitions of property and equipment and investment in software.

#### Net Cash Provided By Financing Activities

Our net borrowings on our credit agreement correspond with the slow payments received this quarter.

At September 30, 2022, our restricted cash balance was inflated by a large customer receivable of $60.4 million, which was paid to us after we had sold the balance to a third party, resulting in a financing cash inflow. At December 2022, a similar event arose for a sum of $52.3 million. Absent further transactions, we anticipate a financing cash outflow of $52.3 million related to this cash balance at March 31, 2023.

### Cash in Foreign Locations

We have no requirement to remit funds from our foreign locations to the United States. We will continue to explore opportunities to remit additional funds, taking into consideration the working capital requirements and relevant tax rules in each jurisdiction. When we are unable to remit funds back without incurring a penalty, we will consider these funds indefinitely reinvested until such time as these restrictions are changed. As a result, we do not record U.S. deferred income taxes on any funds held in foreign jurisdictions. We have not attempted to calculate our potential liability from any transfer of these funds, as any such transaction might include tax planning strategies that we have not fully explored. Accordingly, it is not possible to estimate the potential tax obligations if we were to remit all of our funds from foreign locations to the United States.

### Free Cash Flow

*Table MD&A 8: Free Cash Flow*

*(in thousands)*

|  | For the Three Months Ended December 31, 2022 | December 31, 2021 |
| --- | ---: | ---: |
| Net cash used in operating activities | $(134,659) | $(2,919) |
| Purchases of property and equipment and capitalized software | (15,697) | (6,327) |
| Free cash flow | $(150,356) | $(9,246) |

### Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires us to make estimates, judgments, and assumptions that affect the amounts reported. Actual results could differ from those estimates. The 2022 Form 10-K, as filed with the SEC on November 22, 2022, includes a summary of critical accounting policies we believe are the most important to aid in understanding our financial results. There have been no changes to those critical accounting policies that have had a material impact on our reported amounts of assets, liabilities, revenues, or expenses during the three months ended December 31, 2022.

### Non-GAAP and Other Measures

We utilize non-GAAP measures where we believe it will assist users of our financial statements in understanding our business. The presentation of these measures is meant to complement, but not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as an alternative to revenue growth, cash flows from operating activities, net income, or earnings per share as measures of performance. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.

For the three months ended December 31, 2022, 15% of our revenue was generated outside the U.S. We believe that users of our financial statements wish to understand the performance of our foreign operations using a methodology that excludes the effect of year-over-year exchange rate fluctuations. To calculate year-over-year currency movement, we determine the current fiscal year's results for all foreign businesses using the exchange rates in the prior fiscal year.

In recent years, we have made a number of acquisitions. We believe users of our financial statements wish to evaluate the performance of our operations, excluding changes that have arisen due to businesses acquired or disposed of. We identify acquired revenue and cost of revenue by showing these results for periods for which no comparative results exist within our financial statements. We identify revenue and cost of revenue that has been disposed of in a similar manner. This information is supplemented by our calculations of organic growth. To calculate organic growth, we compare current fiscal year results excluding transactions from acquisitions or disposals, to our prior fiscal year results.

Our recent acquisitions have resulted in significant intangible assets which are amortized over their estimated useful lives. We believe users of our financial statements wish to understand the performance of the business by using a methodology that excludes the amortization of our intangible assets. Accordingly, we have calculated our operating profit, net income, and earnings per share, excluding the effect of the amortization of intangible assets. We have included the following table showing our reconciliation of these income measures to their corresponding U.S. GAAP measures.

*Table MD&A 9: Non-GAAP Adjusted Results Excluding Amortization of Intangible Assets*

*(dollars in thousands, except per share data)*

|  | For the Three Months Ended December 31, 2022 | December 31, 2021 |
| --- | ---: | ---: |
| Operating income | $74,777 | $81,529 |
| Add back: Amortization of intangible assets | 23,518 | 22,405 |
| Adjusted operating income excluding amortization of intangible assets (Non-GAAP) | $98,295 | $103,934 |
| Adjusted operating income margin excluding amortization of intangible assets (Non-GAAP) | 7.9% | 9.0% |
| Net income | $39,995 | $53,330 |
| Add back: Amortization of intangible assets, net of tax | 17,360 | 16,530 |
| Adjusted net income excluding amortization of intangible assets (Non-GAAP) | $57,355 | $69,860 |
| Diluted earnings per share | $0.65 | $0.85 |
| Add back: Effect of amortization of intangible assets on diluted earnings per share | 0.29 | 0.27 |
| Adjusted diluted earnings per share excluding amortization of intangible assets (Non-GAAP) | $0.94 | $1.12 |

In order to sustain our cash flows from operations, we regularly refresh our fixed assets and technology. We believe that users of our financial statements wish to understand the cash flows that directly correspond with our operations and the investments we must make in those operations using a methodology that combines operating cash flows and capital expenditures. We provide free cash flow to complement our statement of cash flows. Free cash flow shows the effects of our operations and replacement capital expenditures and excludes the cash flow effects of acquisitions, purchases of our common stock, dividend payments, and other financing transactions. We have provided a reconciliation of cash flows from operations to free cash flow in "Liquidity and Capital Resources."

To sustain our operations, our principal source of financing comes from receiving payments from our customers. We believe that users of our financial statements wish to evaluate our efficiency in converting revenue into cash receipts. Accordingly, we provide DSO, which we calculate by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the period. Revenue per day for a quarter is determined by dividing total revenue by 91 days.

Our Credit Agreement includes the defined term Consolidated EBITDA and our calculation of Adjusted EBITDA conforms to the Credit Agreement. We believe our investors appreciate the opportunity to understand the possible restrictions which arise from our Credit Agreement.

- Adjusted EBITDA is also a useful measure of performance that focuses on the cash generating capacity of the business as it excludes the non-cash expenses of depreciation and amortization, and makes for easier comparisons between the operating performance of companies with different capital structures by excluding interest expense and therefore, the impacts of financing costs.
- The measure of Adjusted EBITA is a step in calculating Adjusted EBITDA and facilitates comparisons to similar businesses as it isolates the amortization effect of business combinations.
- The Credit Agreement requires us to adjust for unusual, non-recurring expenses, certain non-cash adjustments and estimated synergies from acquisitions.

We have provided a reconciliation from net income to Non-GAAP Adjusted EBITA, Non-GAAP Adjusted EBITDA, and Non-GAAP Adjusted EBITDA per our Credit Agreement, as shown below.

*Table MD&A 10: Reconciliation of Net Income to Non-GAAP Adjusted EBITA, Non-GAAP Adjusted EBITDA, and Non-GAAP Adjusted EBITDA per our Credit Agreement*

*(in thousands)*

|  | For the Three Months Ended December 31, 2022 | For the Trailing Twelve Months Ended December 31, 2022 |
| --- | ---: | ---: |
| Net income | $39,995 | $190,493 |
| Adjustments: |  |  |
| Interest expense | 21,606 | 57,933 |
| Other (income)/expense, net | (266) | 2,258 |
| Provision for income taxes | 13,442 | 68,462 |
| Amortization of intangibles | 23,518 | 91,578 |
| Stock compensation expense | 4,403 | 26,631 |
| Acquisition-related expenses | 1,394 | (764) |
| Gain on sale of land and building | — | (11,046) |
| Adjusted EBITA - Non-GAAP measure | 104,092 | 425,545 |
| Depreciation and amortization of property, equipment, and capitalized software | 12,280 | 43,245 |
| Adjusted EBITDA - Non-GAAP measure | 116,372 | $468,790 |
| Adjustments permitted by our credit agreement - Non-GAAP measure | 13,513 | 40,328 |
| Adjusted EBITDA per our credit agreement - Non-GAAP measure | $129,885 | $509,118 |

27

## Market risk

As filed, 517 characters.

In the normal course of business, we are exposed to financial risks such as changes in interest rates, foreign currency exchange rates, and counterparty risk. We use derivative instruments to manage selected interest rate exposures. The Company's market rate risk disclosures set forth in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" on the 2022 Form 10-K, as filed with the SEC on November 22, 2022, have not changed materially during the three month period ended December 31, 2022.

## Controls and procedures

As filed, 1,542 characters.

### Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that these disclosure controls and procedures were effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

### Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 187 characters.

There were no material changes during the three months ended December 31, 2022, to the risk factors previously disclosed in the 2022 Form 10-K, as filed with the SEC on November 22, 2022.

Filed Feb 9, 2023.
Source: SEC EDGAR, the filing index for accession 0001032220-23-000004. Last ingested by Listed: Oct 24, 2026, 15:04 ET. No prices; not investment advice.
